Full Length Research Paper
References
|
Afar U, Khaliq S, Ahmad HU, Manzoor S,and Lone KP (2018). Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links. Hormones 17(3):299-313. |
|
|
Ahjoub S, Massrou-Roudsari J (2012) Role of oxidative stress in the pathogenesis of metabolic syndrome. Caspian internal medicine 3(1):386-396. |
|
|
Alberti KGMM, Zimmet P, Shaw J (2005). International Diabetic Federation, (IDF), Epidemiology Task Force Consensus Group. The Metabolic Syndrome - a new worldwide definition Lancet 366(9491):1059-1062. |
|
|
Balkau B, Charles MA (1999). Comments on the provisional report from the WHO Consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetic Medicine 16:442-443. |
|
|
Belson Kennedy D (2004). The obesity epidemic. Science 304:1413-1415 |
|
|
Chlup R, Bartek J, Reznickova M, Zapletalová J, Doubravová, B, Chlupová L, Simánek V (2004). Determination of the glycaemic index of selected foods (white bread and cereal bars) in healthy persons. Biomed Papers 148(1):17-25. |
|
|
De-Fronzo RA, Ferrranni E (1991). Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerotic cardiovascular disease. Diabetes Care 14 (3):173-174. |
|
|
Department of Agriculture, Department of Health and Human Services, (1980). Nutrition and your health: Home and Garden Bulletin No 232. Washington DC: Government Printing Office. |
|
|
Dunaif A, Xia J, Book CB, Schenker E, Tang Z (1995). Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. The Journal of clinical investigation 96(2):801-810. |
|
|
Fadzlina AA, Harun F, Nurul Haniza MY, Al Sadat N, Murray L, Cantwell MM, Su TT, Majid HA, Jalaludin MY (2014). Metabolic syndrome among 13 year old adolescents: prevalence and risk factors. BMC Public Health 14(3):1-8 |
|
|
Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A (2014). Gut microbiota and metabolic syndrome. World Journal Gastroenterol 20(43):16079 |
|
|
Fontaine KR, Cheskin LJ, Barofsky. I (1996). Health-related quality of life in obese persons seeking treatment. Journal Family Practice 43(1):265-270. |
|
|
Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB (1996). How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups. American Journal of Epidemiology 143(1):228-239. |
|
|
Giuliante, R, Sartini D, Bacchetti T, Rocchetti R, Klöting I, Polidori C, Emanuelli M (2015). Potential involvement of nicotinamide N-methyltransferase in the pathogenesis of metabolic syndrome. Metabolic Syndrome and Related Disorders 13(4):165-170. |
|
|
Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C (2004). Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109(3):433-438. |
|
|
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Costa F (2005a). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112(17):2735-2752. |
|
|
Grundy SM, Cleeman JI, Daurels SR (2005b). Diagnosis and management of the metabolic syndrome; a statement for healthcare professionals: an American Heart Association/National Heart, Lung, and Blood Institute scientific Statement. Circulation 112(21):2735-2752. |
|
|
Han TS, van Leer EM, Seidell JC, Lean MEJ (1995). Waist circumference action level in the identification of cardiovascular risk factors: prevalence study in a random sample. British Medical Journal 311(7017):1401-1405. |
|
|
Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM (2004). Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. Jama 291(23):2847-2850. |
|
|
Innocent O, Chinemerem O, Emmanuel N, Samuel U, Elizabeth A, Clementina E, Ogbu O (2022). Frequency of diagnostic combination of risk factors of metabolic syndrome associated with diabetes, hypertension, chronic kidney disease and apparent health. Journal of Medical Laboratory and Diagnosis 12(1):6-10. |
|
|
James PT, Leach R, Kalamara E, Shayeghi M (2001). The worldwide obesity epidemic. Obesity Research 9(Suppl 4):228S-233S. |
|
|
Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM (1976). The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. New England Journal Medicine 294(13):739-745. |
|
|
Kahn CR, Wang G, Lee KY (2019). Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. The Journal of clinical investigation 129(10):3990-4000. Doi: 10.1172/JCI129187 |
|
|
Kassi PP, Kaltsas G, Chrousos G (2011). Metabolic syndrome: definitions and controversies. BMC medicine 9:1-13. |
|
|
Klein BE, Klein R, Lee KE (2002). Components of the metabolic syndrome and risk of cardiovascular disease and diabetes beaver dam. Diabetes Care 25(10):1790-1794. |
|
|
Krauss RM, Winston M, Fletcher RN, Grundy S.M (1998). Obesity: impact of cardiovascular disease. Circulation 98(15):1472-1476. |
|
|
Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA (2002). Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. American Journal of Epidemiology 156(11):1070-1077. |
|
|
Leibel RL, Rosenbaum M, Hirsch J (1995). Changes in energy expenditure resulting from altered body weight. New England Journal of Medicine 323(10):621-628. |
|
|
Le-Roith DA, Zick Y (2001). Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 24(3):588-597. |
|
|
Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH (2010). The role of fructose in the pathology of non-alcoholic fatty liver disease and metabolic syndrome. Nature reviews Gastroenterology & hepatology 7(5):251-264. |
|
|
Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM (2003). The metabolic syndrome as predictor of type 2 diabetes: The San Antonio Heart study. Diabetes Care 26(11):3153-3159. |
|
|
MacMahon S, Peto R, Cutler J, Collins R, Solie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler, J, (1990). Blood pressure, stroke and coronary heart disease, 1: prolonged differences in blood pressure perspective observational studies corrected for the regression dilution bias. Lancet 335(8692):765-774. |
|
|
Misra A, Vikram NK (2004). Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition 20(5):482-491. |
|
|
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH (1999). The disease burden associated with overweight and obesity. JAMA 282(16):1523-1529. |
|
|
National Cholesterol Education Programme (NCEP) (2002). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in adults, (Adult Treatment Panel 111): final report. Circulation 106(25):3143-3421 |
|
|
Ogbu ISI (2009). Incidence of metabolic syndrome among hospital-based patients in the University of Nigeria Teaching Hospital and apparently healthy people in Enugu metropolis. A PhD thesis, University of Calabar, Nigeria. |
|
|
Ogbu ISI, Udoh AE, Oforegbu EN (2013a). The prevalence of the metabolic syndrome among type 2 diabetes patients in Enugu, Southeastern Nigera. World Journal of Medical Sciences Recourses 1:6-11. |
|
|
Ookonia S, Pirola CJ (2016). Non alcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis. Hepatology 64(5):1417-1420. |
|
|
Oraitis AG, Block T, Nguyen D, Belanoff JK (2017). The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness. The Journal of steroid biochemistry and molecular biology. 165:114-120. |
|
|
Otani H (2011). Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxidants & redox signaling, 15(7):1911-1926. |
|
|
Parekh PJ, Arusi E, Vinik AI, Johnson DA (2014). The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome. Frontiers in endocrinology 5:47 |
|
|
Porte D Jr, Baskin DG, Schwartz MW (2002). Insulin signaling in the central nervous system. Diabetes 54(5):1264-1276. |
|
|
Porte D Jr, Baskin DG, Schwartz MW (2005). Leptin and insulin action in the central nervous system. Nutrition Review 60:520-529. |
|
|
Roach P, Zick Y, Formisano P, Accili D, Taylor SI, Gorden P (1994). A novel human IR gene mutation uniquely inhibits insulin binding without impairing posttranslational processing. Diabetes 43:1096-1102. |
|
|
Schreiner PJ, Terry JG, Evans GW, Hinson WH, Crouse III JR, Heiss G (1996). Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices: The Atherosclerosis Risk in Communities Study. American journal of epidemiology 144(4):335-345. |
|
|
Schwartz MW (2000). Central nervous system control of food intake. Nature 404:661-671. |
|
|
Shahaz T, Mohammed A (2018). The role of lipids in the pathogenesis of metabolic syndrome in adolescents. Exptal and Clin Endocrinol Diabetes 126(10):14-22. |
|
|
Smith M, Honce R, Schultz-Cherry S (2020). Metabolic syndrome and viral pathogenesis: lessons from influenza and coronaviruses. Journal of virology 94(18):e00665-20. |
|
|
Titov VN (2014). Leptin and adeponectin in pathogenesis of metabolic syndrome. Klinicheskaia Meditsina 92(4):20-29. |
|
|
Virkamaki A, Ueki K, Kahn CR (1996). Protein-protein interaction in insulin signaling and the molecular mechanism of insulin resistance. Journal of Clinical Investigations 103:931-943. |
|
|
Wang CC, Goalstone ML, Draznin B (2004) Molecular mechanisms of insulin resistance that impact on cardiovascular biology. Diabetes 53(11):2735-2740. |
|
|
Wang HH, Lee DK, Liu M, Portincasa P, Wang DQ (2020). Novel insight into the pathogenesis and management of the metabolic syndrome. Pediatric Gastroenterology, Hepatology and Nutrition 23(3):189-230 |
|
|
Wilson PW, Grundy SM (2003). The metabolic syndrome: a practical guide to origins and treatment: Part II. Circulation 108(13):1537-1540. |
|
|
World Health Organization (2000). Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894; i - ix, 1 -25. |
|
|
World Health Organization (2000). Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894; i - ix, 1 -253. |
|
|
World Health Organization (WHO) (1995). Physical status: the use and interpretation of anthropometry; report of a WHO Expert Committee. WHO Technical Report Series 854:1-452. |
|
|
Yang S, Zhang L (2004). Glucocorticoids and vascular reactivity. Current Opinions in Vascular Pharmacology 2(1):1-2. |
|
|
Yu SS K, Castillo DC, Courville AB, Summer AE (2012). The triglyceride Paradox in people of African descent. Metabolic syndrome and related disorders 10(2):77-82. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
